Chugai Pharmaceutical Dirección
Dirección controles de criterios 1/4
El CEO de Chugai Pharmaceutical es Osamu Okuda , nombrado en Mar 2020, tiene una permanencia de 4.67 años. compensación anual total es ¥375.00M, compuesta por 31.7% salario y 68.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.01% de las acciones de la empresa, por valor de ¥1.01B. La antigüedad media del equipo directivo y de la junta directiva es de 3.8 años y 1.7 años, respectivamente.
Información clave
Osamu Okuda
Chief Executive Officer (CEO)
JP¥375.0m
Compensación total
| Porcentaje del salario del CEO | 31.7% |
| Permanencia del CEO | 4.7yrs |
| Participación del CEO | 0.01% |
| Permanencia media de la dirección | 3.8yrs |
| Promedio de permanencia en la Junta Directiva | 1.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Oct 30
Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next
Oct 29Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Oct 15Should You Be Adding Chugai Pharmaceutical (TSE:4519) To Your Watchlist Today?
Oct 12Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Sep 24Results: Chugai Pharmaceutical Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Jul 30Chugai Pharmaceutical (TSE:4519) Is Due To Pay A Dividend Of ¥41.00
Jul 27Estimating The Intrinsic Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)
Jul 15Chugai Pharmaceutical (TSE:4519) Is Increasing Its Dividend To ¥41.00
Jun 19Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Business Is Trailing The Market But Its Shares Aren't
Jun 17Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year
May 04We Think That There Are Some Issues For Chugai Pharmaceutical (TSE:4519) Beyond Its Promising Earnings
May 01Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Apr 26Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected
Mar 01Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | JP¥387b |
| Jun 30 2024 | n/a | n/a | JP¥355b |
| Mar 31 2024 | n/a | n/a | JP¥326b |
| Dec 31 2023 | JP¥375m | JP¥119m | JP¥325b |
| Sep 30 2023 | n/a | n/a | JP¥337b |
| Jun 30 2023 | n/a | n/a | JP¥327b |
| Mar 31 2023 | n/a | n/a | JP¥316b |
| Dec 31 2022 | JP¥298m | JP¥108m | JP¥374b |
| Sep 30 2022 | n/a | n/a | JP¥371b |
| Jun 30 2022 | n/a | n/a | JP¥389b |
| Mar 31 2022 | n/a | n/a | JP¥387b |
| Dec 31 2021 | JP¥252m | JP¥85m | JP¥303b |
| Sep 30 2021 | n/a | n/a | JP¥256b |
| Jun 30 2021 | n/a | n/a | JP¥231b |
| Mar 31 2021 | n/a | n/a | JP¥211b |
| Dec 31 2020 | JP¥84m | JP¥40m | JP¥215b |
Compensación vs. Mercado: La compensación total de Osamu($USD2.43M) está por encima de la media de empresas de tamaño similar en el mercado JP ($USD1.38M).
Compensación vs. Ingresos: La compensación de Osamu ha aumentado más de un 20% en el último año.
CEO
Osamu Okuda (61 yo)
4.7yrs
Permanencia
JP¥375,000,000
Compensación
Dr. Osamu Okuda serves as Representative Director and President at Chugai Pharmaceutical Co., Ltd. since March 30, 2020 and its Chief Executive Officer since March 23, 2021. He serves as Chairman at Chugai...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 4.7yrs | JP¥375.00m | 0.0096% ¥ 1.0b | |
| Executive VP | less than a year | sin datos | 0.00012% ¥ 12.6m | |
| Executive of Investor Relations Group & Corporate Communications Department | no data | sin datos | sin datos | |
| VP and Head of Quality | less than a year | sin datos | sin datos | |
| Head of Marketing & Sales Division | no data | sin datos | sin datos | |
| Executive Vice President | less than a year | sin datos | sin datos | |
| Executive Vice President | 3.8yrs | sin datos | sin datos | |
| Senior VP & Full-time Audit Supervisory Board Member | 9.8yrs | sin datos | 0.0030% ¥ 313.0m | |
| Executive VP & Head of PHC Solution Unit | 4.8yrs | sin datos | sin datos | |
| Executive Vice President | no data | sin datos | sin datos | |
| Head of PHC Solution Department | no data | sin datos | sin datos | |
| VP & Head of Research Division | no data | sin datos | sin datos |
3.8yrs
Permanencia media
61yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 4519 se considera experimentado (3.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 4.7yrs | JP¥375.00m | 0.0096% ¥ 1.0b | |
| Executive VP | less than a year | sin datos | 0.00012% ¥ 12.6m | |
| Senior VP & Full-time Audit Supervisory Board Member | 3.7yrs | sin datos | 0.0030% ¥ 313.0m | |
| Executive VP | less than a year | sin datos | 0.00018% ¥ 18.9m | |
| Member of the International Advisory Council | no data | sin datos | sin datos | |
| Honorary Chairman & Senior Advisor | 4.7yrs | JP¥211.00m | sin datos | |
| Member of the International Advisory Council | no data | sin datos | sin datos | |
| Member of the International Advisory Council | no data | sin datos | sin datos | |
| Member of the International Advisory Council | no data | sin datos | sin datos | |
| Chairman of the International Advisory Council | no data | sin datos | sin datos | |
| Outside Independent Director | 1.7yrs | sin datos | sin datos | |
| Non-Executive Director | 1.7yrs | sin datos | sin datos |
1.7yrs
Permanencia media
75yo
Promedio de edad
Junta con experiencia: La junta directiva de 4519 no se considera experimentada (1.7 años de permanencia promedio), lo que sugiere una nueva junta directiva.